Matthew Gline
CIK 1750094 · CEO · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$622.58M
Companies
2
Total Filings
72
Lifetime Open-Market Net
-$71.73M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | CEO | 16,659,945 | $37.37 | $622.58M | -$69.51M | 30 | 2026-07-02 |
| Roivant Sciences Ltd. (ROIVW) Delisted | CEO | 1,051,732 | $2.75 | $2.89M | -$2.22M | 26 | 2023-08-29 |
Recent Filings · Page 4 of 8
72 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-12-22 | ROIV | Tax (F) | −10,945 | -$109.0K | EDGAR |
| 2023-11-27 | ROIV | Other (J) | −11,318 | -$98.2K | EDGAR |
| 2023-11-21 | ROIV | Notice (144) | −19,792 | -$174.2K | EDGAR |
| 2023-10-26 | ROIV | Other (J) | −12,489 | -$112.3K | EDGAR |
| 2023-10-23 | ROIV | Notice (144) | −19,792 | -$191.2K | EDGAR |
| 2023-09-29 | ROIV | Mixed | +7,519 | -$129.8K | EDGAR |
| 2023-09-28 | ROIV | Notice (144) | −10,243 | -$135.1K | EDGAR |
| 2023-09-26 | ROIV | Other (J) | −11,227 | -$114.4K | EDGAR |
| 2023-09-21 | ROIV | Notice (144) | −19,792 | -$204.5K | EDGAR |
| 2023-08-29 | Roivant Sciences Ltd. (ROIVW) Delisted | Mixed | +5,304 | -$76.3K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.